Seeking proposals to ensure the nation is prepared for the next influenza pandemic. These partnerships will support @US_FDA-licensed manufacturing of influenza antigens & adjuvants and ensure vaccine capacity is available when needed. Proposals due 10/30: ow.ly/k3jL50ZAZfm
Advancing countermeasures against 21st century health threats by bringing together public private partnerships and advancing innovation. Part of HHS/ASPR.
- The DeepView AI-Burn System from our partner @Spectral_MDAI is the most recent BARDA-supported burn product to receive FDA approval, licensure or clearance. ️This AI-enabled software is used on Spectral AI’s imaging device to assess the size & healing potential of a burn wound.
- Under Project BioShield, we're partnering w/ @VericelCorp to ensure access to FDA-licensed NexoBrid during a disaster. Vericel will manage product storage to guarantee availability & reduce costs, and further develop NexoBrid to treat blast injuries. medicalcountermeasures.gov/barda/cbrn
- We awarded a Project BioShield contract to @AvitaMedical for RECELL, an FDA-approved autograft-sparing device that uses a small sample of a patient’s own skin to treat full-thickness burns & trauma, enhancing readiness for radiological & nuclear incidents: ow.ly/AA7Z50Z9mT2
- This #BARDAInnovation Spotlight highlights the Quic Liver + Kidney test being developed by @in_Diagnostics. Their test pairs with a smartphone app to assess organ health at home, enabling decentralized monitoring during both daily care and emergencies. 🔗: drive.hhs.gov/map/index.html

